• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NEURONETICS, INC. NEUROSTAR ADVANCED THERAPY; TRANSCRANIAL MAGNETIC STIMULATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NEURONETICS, INC. NEUROSTAR ADVANCED THERAPY; TRANSCRANIAL MAGNETIC STIMULATOR Back to Search Results
Model Number NEUROSTAR ADVANCED THERAPY V 3.0
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Convulsion/Seizure (4406)
Event Date 03/05/2024
Event Type  Injury  
Event Description
Provider called neuronetics to report that one of their patients experienced a seizure during her 5th treatment session.An ambulance was called after the event occurred and the patient was taken to the er.
 
Manufacturer Narrative
Neuronetics received a call from a provider reporting one of their patients experienced a seizure during their 5th treatment sessions.When speaking with the provider regarding the event, the provider themselves does not believe that the patient experienced an "actual seizure".The provider believes that the patient may have suffered a "pseudo-seizure" as the patient reportedly: was alert and oriented following the event, there was no post-ictal stage, did not loose consciousness, and was responsive.The provider believes that this may have been caused by the increase in treatment power.The provider reported that the patient has a smaller head and that the increase in intensity may have resulted in the patient's motor strip being stimulated.After the event occurred, the patient was sent to the er as a precaution and to be checked out.The patient reportedly did not have a full work up done at the er and was not seen by any specialist while there.Since the event, the patient has returned to tms treatment with an altered protocol and has not had any issues since.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEUROSTAR ADVANCED THERAPY
Type of Device
TRANSCRANIAL MAGNETIC STIMULATOR
Manufacturer (Section D)
NEURONETICS, INC.
3222 phoenixville pike
malvern PA 19355
Manufacturer (Section G)
NEURONETICS, INC.
3222 phoenixville pike
malvern PA 19355
Manufacturer Contact
anna gorbunov
3222 phoenixville pike
malvern, PA 19355
MDR Report Key18964378
MDR Text Key338429875
Report Number3004824012-2024-00009
Device Sequence Number1
Product Code OBP
UDI-Device Identifier00869378000117
UDI-Public00869378000117
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K201158
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 03/22/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/22/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberNEUROSTAR ADVANCED THERAPY V 3.0
Device Catalogue Number81-02315-000
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/05/2024
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Treatment
SERTRALINE 200 MG PO QD; VRAYLAR 3 MG PO QD; XANAX 0.5 MG PO PRN ANXIETY ATTACKS
Patient Outcome(s) Other;
Patient Age17 YR
Patient SexFemale
-
-